naltrexone has been researched along with alanine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cicero, TJ; Meyer, ER; Newman, KS | 1 |
Bullmore, ET; Dodds, C; Fernando, D; Fletcher, PC; Hosking, LK; Korzeniowska, A; Maltby, K; Miller, SR; Nathan, PJ; Nestor, LJ; Richards, DB; Sarai, BK; Subramaniam, N; Vasist Johnson, L; Warren, L; Waterworth, D; Win, B; Ziauddeen, H | 1 |
1 trial(s) available for naltrexone and alanine
Article | Year |
---|---|
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Topics: Adolescent; Adult; Aged; Alanine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drinking; Eating; Female; Glycine; Humans; Indans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Triazoles; Young Adult | 2016 |
1 other study(ies) available for naltrexone and alanine
Article | Year |
---|---|
Testosterone does not influence opiate binding sites in the male rat brain.
Topics: Alanine; Animals; Brain; Castration; Dihydromorphine; Hypothalamus; Male; Naltrexone; Rats; Receptors, Opioid; Testosterone | 1983 |